These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

480 related items for PubMed ID: 9685159

  • 1. Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis.
    Shih DM, Gu L, Xia YR, Navab M, Li WF, Hama S, Castellani LW, Furlong CE, Costa LG, Fogelman AM, Lusis AJ.
    Nature; 1998 Jul 16; 394(6690):284-7. PubMed ID: 9685159
    [Abstract] [Full Text] [Related]

  • 2. The PON1 gene and detoxication.
    Furlong CE, Li WF, Brophy VH, Jarvik GP, Richter RJ, Shih DM, Lusis AJ, Costa LG.
    Neurotoxicology; 2000 Aug 16; 21(4):581-7. PubMed ID: 11022865
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Genetically determined susceptibility to organophosphorus insecticides and nerve agents: developing a mouse model for the human PON1 polymorphism.
    Furlong CE, Li WF, Costa LG, Richter RJ, Shih DM, Lusis AJ.
    Neurotoxicology; 1998 Aug 16; 19(4-5):645-50. PubMed ID: 9745924
    [Abstract] [Full Text] [Related]

  • 5. Paraoxonase activity is reduced by a pro-atherosclerotic diet in rabbits.
    Mackness M, Boullier A, Hennuyer N, Mackness B, Hall M, Tailleux A, Duriez P, Delfly B, Durrington P, Fruchart JC, Duverger N, Caillaud JM, Castro G.
    Biochem Biophys Res Commun; 2000 Mar 05; 269(1):232-6. PubMed ID: 10694505
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Human plasma paraoxonase (HuPON1): an anti-atherogenic enzyme with organophosphate hydrolase activity].
    Josse D, Masson P.
    Ann Pharm Fr; 2001 Apr 05; 59(2):108-18. PubMed ID: 11320335
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Serum paraoxonase status: a major factor in determining resistance to organophosphates.
    Li WF, Costa LG, Furlong CE.
    J Toxicol Environ Health; 1993 Apr 05; 40(2-3):337-46. PubMed ID: 7693961
    [Abstract] [Full Text] [Related]

  • 14. Mildly oxidized LDL induces an increased apolipoprotein J/paraoxonase ratio.
    Navab M, Hama-Levy S, Van Lenten BJ, Fonarow GC, Cardinez CJ, Castellani LW, Brennan ML, Lusis AJ, Fogelman AM, La Du BN.
    J Clin Invest; 1997 Apr 15; 99(8):2005-19. PubMed ID: 9109446
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.